AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
DESIGN OF IN-VITRO STUDIES TO PREDICT IN-VIVO INHIBITORY DRUG-DRUG INTERACTIONS
Authors: BENEDETTI MS BANI M
Citation: Ms. Benedetti et M. Bani, DESIGN OF IN-VITRO STUDIES TO PREDICT IN-VIVO INHIBITORY DRUG-DRUG INTERACTIONS, Pharmacological research, 38(2), 1998, pp. 81-88
(R)SALSOLINOL N-METHYLTRANSFERASE ACTIVITY INCREASES IN PARKINSONIAN LYMPHOCYTES
Authors: NAOI M MARUYAMA W NAKAO N IBI T SAHASHI K BENEDETTI MS
Citation: M. Naoi et al., (R)SALSOLINOL N-METHYLTRANSFERASE ACTIVITY INCREASES IN PARKINSONIAN LYMPHOCYTES, Annals of neurology, 43(2), 1998, pp. 212-216
MONOAMINE OXIDASES AND RELATED AMINE OXIDASES AS PHASE-I ENZYMES IN THE METABOLISM OF XENOBIOTICS
Authors: BENEDETTI MS TIPTON KF
Citation: Ms. Benedetti et Kf. Tipton, MONOAMINE OXIDASES AND RELATED AMINE OXIDASES AS PHASE-I ENZYMES IN THE METABOLISM OF XENOBIOTICS, Journal of neural transmission. Supplementum, (52), 1998, pp. 149-171
THE OXIDATION OF DOPAMINE AND EPININE BY THE 2 FORMS OF MONOAMINE-OXIDASE FROM RAT-LIVER
Authors: BENEDETTI MS SANSON G BONA L GALLINA M PERSIANI S TIPTON KF
Citation: Ms. Benedetti et al., THE OXIDATION OF DOPAMINE AND EPININE BY THE 2 FORMS OF MONOAMINE-OXIDASE FROM RAT-LIVER, Journal of neural transmission. Supplementum, (52), 1998, pp. 233-238
DETERMINATION OF TUROSTERIDE, A NEW INHIBITOR OF 5-ALPHA-REDUCTASE, IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION
Authors: BASILEO G CASATI M PIANEZZOLA E BENEDETTI MS
Citation: G. Basileo et al., DETERMINATION OF TUROSTERIDE, A NEW INHIBITOR OF 5-ALPHA-REDUCTASE, IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography B. Biomedical sciences and applications, 688(1), 1997, pp. 117-125
REVIEW OF THE PHARMACOKINETICS AND METABOLISM OF REBOXETINE, A SELECTIVE NORADRENALINE REUPTAKE INHIBITOR
Authors: DOSTERT P BENEDETTI MS POGGESI I
Citation: P. Dostert et al., REVIEW OF THE PHARMACOKINETICS AND METABOLISM OF REBOXETINE, A SELECTIVE NORADRENALINE REUPTAKE INHIBITOR, European neuropsychopharmacology, 7, 1997, pp. 23-35
PRELIMINARY PHARMACOKINETIC STUDY OF IBUPROFEN ENANTIOMERS AFTER ADMINISTRATION OF A NEW ORAL FORMULATION (IBUPROFEN ARGININE) TO HEALTHY MALE-VOLUNTEERS
Authors: FORNASINI G MONTI N BROGIN G GALLINA M EANDI M PERSIANI S BANI M DELLAPEPA C ZARA G BENEDETTI MS
Citation: G. Fornasini et al., PRELIMINARY PHARMACOKINETIC STUDY OF IBUPROFEN ENANTIOMERS AFTER ADMINISTRATION OF A NEW ORAL FORMULATION (IBUPROFEN ARGININE) TO HEALTHY MALE-VOLUNTEERS, Chirality, 9(3), 1997, pp. 297-302
PHARMACOKINETICS OF REBOXETINE ENANTIOMERS IN THE DOG
Authors: FRIGERIO E BENECCHI A BRIANCESCHI G PELLIZZONI C POGGESI I BENEDETTI MS DOSTERT P
Citation: E. Frigerio et al., PHARMACOKINETICS OF REBOXETINE ENANTIOMERS IN THE DOG, Chirality, 9(3), 1997, pp. 303-306
IS INDUCTION OF CYTOCHROME-P450 ASSOCIATED WITH OXIDATIVE STRESS IN-VIVO
Authors: BENEDETTI MS BROGIN G BANI M OESCH F
Citation: Ms. Benedetti et al., IS INDUCTION OF CYTOCHROME-P450 ASSOCIATED WITH OXIDATIVE STRESS IN-VIVO, The FASEB journal, 11(9), 1997, pp. 280-280
CLINICAL AND PHARMACOKINETIC EVALUATION OF L-DOPA AND CABERGOLINE COTREATMENT IN PARKINSONS-DISEASE
Authors: DELDOTTO P COLZI A MUSATTI E BENEDETTI MS PERSIANI S FARIELLO R BONUCCELLI U
Citation: P. Deldotto et al., CLINICAL AND PHARMACOKINETIC EVALUATION OF L-DOPA AND CABERGOLINE COTREATMENT IN PARKINSONS-DISEASE, Clinical neuropharmacology, 20(5), 1997, pp. 455-465
A STUDY OF THE PHARMACOKINETICS AND TOLERABILITY OF RITIPENEM ACOXIL IN HEALTHY-VOLUNTEERS FOLLOWING MULTIPLE ORAL DOSING
Authors: POGGESI I SPINELLI R FRIGERIO E BENEDETTI MS CARRA L SASSELLA D RIMOLDI R
Citation: I. Poggesi et al., A STUDY OF THE PHARMACOKINETICS AND TOLERABILITY OF RITIPENEM ACOXIL IN HEALTHY-VOLUNTEERS FOLLOWING MULTIPLE ORAL DOSING, Journal of antimicrobial chemotherapy, 40(2), 1997, pp. 291-294
A NEUROTOXIN N-METHYL(R)SALSOLINOL INDUCES APOPTOTIC CELL-DEATH IN DIFFERENTIATED HUMAN DOPAMINERGIC NEUROBLASTOMA SH-SY5Y CELLS
Authors: MARUYAMA W BENEDETTI MS TAKAHASHI T NAOI M
Citation: W. Maruyama et al., A NEUROTOXIN N-METHYL(R)SALSOLINOL INDUCES APOPTOTIC CELL-DEATH IN DIFFERENTIATED HUMAN DOPAMINERGIC NEUROBLASTOMA SH-SY5Y CELLS, Neuroscience letters, 232(3), 1997, pp. 147-150
THE USE OF PHARMACOSCINTIGRAPHY TO FOCUS THE DEVELOPMENT STRATEGY FORA NOVEL 5-ASA COLON TARGETING SYSTEM (TIME CLOCK(R) SYSTEM)
Authors: STEED KP HOOPER G MONTI N BENEDETTI MS FORNASINI G WILDING IR
Citation: Kp. Steed et al., THE USE OF PHARMACOSCINTIGRAPHY TO FOCUS THE DEVELOPMENT STRATEGY FORA NOVEL 5-ASA COLON TARGETING SYSTEM (TIME CLOCK(R) SYSTEM), Journal of controlled release, 49(2-3), 1997, pp. 115-122
DETERMINATION OF FCE-26644, A NEW POLYSULPHONATED DERIVATIVE OF DISTAMYCIN-A, IN MONKEY PLASMA BY REVERSED-PHASE ION-PAIR HIGHPERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION
Authors: FRIGERIO E MAGI N BENECCHI A PIANEZZOLA E BENEDETTI MS
Citation: E. Frigerio et al., DETERMINATION OF FCE-26644, A NEW POLYSULPHONATED DERIVATIVE OF DISTAMYCIN-A, IN MONKEY PLASMA BY REVERSED-PHASE ION-PAIR HIGHPERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography, 729(1-2), 1996, pp. 237-242
DETERMINATION OF ETHAMBUTOL IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
Authors: BREDA M MARRARI P PIANEZZOLA E BENEDETTI MS
Citation: M. Breda et al., DETERMINATION OF ETHAMBUTOL IN HUMAN PLASMA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION, Journal of chromatography, 729(1-2), 1996, pp. 301-307
SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF 2-PHENYLETHYLAMINE IN HUMAN URINE
Authors: LACROIX R DOSTERT P BENEDETTI MS
Citation: R. Lacroix et al., SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF 2-PHENYLETHYLAMINE IN HUMAN URINE, Journal of chromatography B. Biomedical applications, 681(1), 1996, pp. 185-190
DETERMINATION OF TALLIMUSTINE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: MARRARI P PIANEZZOLA E BENEDETTI MS
Citation: P. Marrari et al., DETERMINATION OF TALLIMUSTINE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 677(1), 1996, pp. 133-139
DETERMINATION OF THE NEW AROMATASE INHIBITOR EXEMESTANE IN BIOLOGICAL-FLUIDS BY AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOLLOWED BY RADIOIMMUNOASSAY
Authors: PERSIANI S BROUTIN F CICIONI P BENEDETTI MS
Citation: S. Persiani et al., DETERMINATION OF THE NEW AROMATASE INHIBITOR EXEMESTANE IN BIOLOGICAL-FLUIDS BY AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY FOLLOWED BY RADIOIMMUNOASSAY, European journal of pharmaceutical sciences, 4(6), 1996, pp. 331-340
INVOLVEMENT OF CYP2D6 BUT NOT CYP2C19 IN NICERGOLINE METABOLISM IN HUMANS
Authors: BOTTIGER Y DOSTERT P BENEDETTI MS BANI M FIORENTINI F CASATI M POGGESTI I ALM C ALVAN G BERTILSSON L
Citation: Y. Bottiger et al., INVOLVEMENT OF CYP2D6 BUT NOT CYP2C19 IN NICERGOLINE METABOLISM IN HUMANS, British journal of clinical pharmacology, 42(6), 1996, pp. 707-711
INDUCING PROPERTIES OF RIFAMPICIN AND RIFABUTIN FOR SELECTED ENZYME-ACTIVITIES OF THE CYTOCHROME-P-450 AND UDP-GLUCURONOSYLTRANSFERASE SUPERFAMILIES IN FEMALE RAT-LIVER
Authors: OESCH F ARAND M BENEDETTI MS CASTELLI MG DOSTERT P
Citation: F. Oesch et al., INDUCING PROPERTIES OF RIFAMPICIN AND RIFABUTIN FOR SELECTED ENZYME-ACTIVITIES OF THE CYTOCHROME-P-450 AND UDP-GLUCURONOSYLTRANSFERASE SUPERFAMILIES IN FEMALE RAT-LIVER, Journal of antimicrobial chemotherapy, 37(6), 1996, pp. 1111-1119
EFFECTS OF DOPAMINE-DERIVED ISOQUINOLINES ON HYDROXYL RADICAL FORMATION BY DOPAMINE AUTOXIDATION
Authors: DOSTERT P LACROIX R MARUYAMA W NAOI M BENEDETTI MS
Citation: P. Dostert et al., EFFECTS OF DOPAMINE-DERIVED ISOQUINOLINES ON HYDROXYL RADICAL FORMATION BY DOPAMINE AUTOXIDATION, Biogenic amines, 12(2), 1996, pp. 149-160
PHARMACOKINETICS OF REBOXETINE IN HEALTHY-VOLUNTEERS, SINGLE AGAINST REPEATED ORAL DOSES AND LACK OF ENZYMATIC ALTERATIONS
Authors: PELLIZZONI C POGGESI I JORGENSEN NP EDWARDS DMF PAUS E BENEDETTI MS
Citation: C. Pellizzoni et al., PHARMACOKINETICS OF REBOXETINE IN HEALTHY-VOLUNTEERS, SINGLE AGAINST REPEATED ORAL DOSES AND LACK OF ENZYMATIC ALTERATIONS, Biopharmaceutics & drug disposition, 17(7), 1996, pp. 623-633
DETERMINATION OF PLASMA-LEVELS OF EXEMESTANE (FCE-24304), A NEW IRREVERSIBLE AROMATASE INHIBITOR, USING THERMOSPRAY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY
Authors: ALLIEVI C ZUGNONI P BENEDETTI MS DOSTERT P
Citation: C. Allievi et al., DETERMINATION OF PLASMA-LEVELS OF EXEMESTANE (FCE-24304), A NEW IRREVERSIBLE AROMATASE INHIBITOR, USING THERMOSPRAY LIQUID-CHROMATOGRAPHY MASS-SPECTROMETRY, Journal of mass spectrometry., 30(5), 1995, pp. 693-697
INDUCING PROPERTIES OF RIFABUTIN, AND EFFECTS ON THE PHARMACOKINETICSAND METABOLISM OF CONCOMITANT DRUGS
Authors: BENEDETTI MS
Citation: Ms. Benedetti, INDUCING PROPERTIES OF RIFABUTIN, AND EFFECTS ON THE PHARMACOKINETICSAND METABOLISM OF CONCOMITANT DRUGS, Pharmacological research, 32(4), 1995, pp. 177-187
PHARMACOKINETICS OF REPEATED LOW-DOSES OF EXEMESTANE (1, 2.5, 5, AND 10 MG) IN POSTMENOPAUSAL HEALTHY-VOLUNTEERS
Authors: PERSIANI S POGGESI I CICIONI P BENEDETTI MS
Citation: S. Persiani et al., PHARMACOKINETICS OF REPEATED LOW-DOSES OF EXEMESTANE (1, 2.5, 5, AND 10 MG) IN POSTMENOPAUSAL HEALTHY-VOLUNTEERS, European journal of cancer, 31A, 1995, pp. 952-952
Risultati: 1-25 | 26-50 | 51-51